Stereotaxis, Inc. (STXS)

Stereotaxis, Inc. in the Healthcare sector is trading at $1.04 with a market capitalization of $111M. Wall Street consensus targets $3.00 (3 analysts), implying a +188.5% move over the next 12 months. The stock is currently near its 52-week low of $1.03, remaining 42.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 12 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.